Central Sensitization Is Common in Axial Spondyloarthritis, Which Could Explain Why Up to 40% of Patients on Biologics Still Have High Levels of Chronic Pain
Could pain symptoms be improved in researchers assess patients’ pain perception as part of their treatment plan?
Continue reading